Research archive
Research published in 2024
98 publications from 2024, newest first.
Compiled automatically by Metronomic.com from PubMed and ClinicalTrials.gov. Automated listing. Each item links to its original source. Last refresh: Nov 15, 2026
Titles appear as published. A listing is not an endorsement, and a single study rarely settles a question. Not medically reviewed. Educational information, not medical advice.
- ReviewCancer Lett2024 Dec 28Precision meets repurposing: Innovative approaches in human papillomavirus and Epstein-Barr virus-driven cancer therapy.Fernandes Q
- StudyNeuro Endocrinol Lett2024 Dec 22A retrospective observational clinical study of triple negative breast cancer cases treated with Di Bella Method: A preliminary data.Di Bella G, et al.
- StudySarcoma2024Oral Etoposide for Relapsed or Refractory Ewing Sarcoma in Adolescent and Adult Patients.Kostos L, et al.
- StudyEJHaem2025 FebCharacteristics of relapsed/refractory diffuse large B-cell lymphoma patients with durable responses to maveropepimut-S, pembrolizumab, and cyclophosphamide: Long-term follow-up from the SPiReL trial.Pandey A, et al.
- ReviewPediatr Discov2024 DecMetronomic chemotherapy in pediatric neuroblastoma.Jiang Y, et al.
- Clinical trialSignal Transduct Target Ther2024 Dec 9Anlotinib plus chemotherapy as a first-line treatment for gastrointestinal cancer patients with unresectable liver metastases: a multicohort, multicenter, exploratory trial.Wu JW, et al.
- StudyBiomedicines2024 Dec 6Mutations in the PIK3C2B, ERBB3, KIT, and MLH1 Genes and Their Relationship with Resistance to Temozolomide in Patients with High-Grade Gliomas.Ortiz Gómez LD, et al.
- StudyIndian J Surg Oncol2024 DecMetronomic Chemotherapy After Palliative Radiotherapy in Rare Soft Tissue Sarcomas: An Insight into Radiation Therapy and the Immune Response.Madabhavi IV, et al.
- Clinical trialBreast2024 DecMetronomic chemotherapy using capecitabine and cyclophosphamide in metastatic breast cancer - efficacy, tolerability and quality of life results from the phase II METRO trial.Larsson K F, et al.
- Meta-analysisJ Gastrointest Cancer2024 DecEfficacy and Safety of Metronomic Capecitabine in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.Gupta N, et al.
- StudyClin Transl Oncol2024 DecEfficacy and safety of metronomic oral vinorelbine and its combination therapy as second- and later-line regimens for advanced non-small-cell lung cancer: a retrospective analysis.Chen S, et al.
- Clinical trialBlood2024 Nov 28A weekly low-dose regimen of decitabine and venetoclax is efficacious and less myelotoxic in a racially diverse cohort.Goldfinger M, et al.
- StudyCureus2024 NovOral Metronomic Therapy: An Effective Palliative Treatment Option for Epithelial Ovarian Cancer.Devi R N, et al.
- StudyToxicol Appl Pharmacol2024 NovIntestinal ABC transporters: Influence on the metronomic cyclophosphamide-induced toxic effect in an obese mouse mammary cancer model.Barranco MM, et al.
- StudyAdv Mater2024 NovTransformable Gel-to-Nanovaccine Enhances Cancer Immunotherapy via Metronomic-Like Immunomodulation and Collagen-Mediated Paracortex Delivery.Jin SM, et al.
- ReviewBlood Rev2024 NovVen the dose matters: Venetoclax dosing in the frontline treatment of AML.Sastow D, et al.
- StudyOral Oncol2024 NovGemcitabine, capecitabine, and tislelizumab in recurrent/metastatic nasopharyngeal carcinoma following prior anti-PD-1 therapy failure: A retrospective study.Yang R, et al.
- ReviewMol Cancer2024 Oct 31Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.Kesharwani P, et al.
- StudyFront Oncol2024A real-world study on the clinicopathological profile, treatment outcomes and health-related quality of life, anxiety and depression among patients with desmoid tumor at two tertiary care centers in India.Tansir G, et al.
- Clinical trialBMC Cancer2024 Oct 18Pyrotinib combined with metronomic etoposide in heavily pretreated HER2-positive metastatic breast cancer: a single-arm, phase II study.Liu J, et al.
- StudyInt J Cancer2024 Oct 15Personalized dendritic cell vaccine in multimodal individualized combination therapy improves survival in high-risk pediatric cancer patients.Kyr M, et al.
- Meta-analysisBMJ Open2024 Oct 11Metronomic chemotherapy for paediatric extracranial solid tumours: a systematic review and meta-analysis of randomised clinical trials.Peinemann F and Hoemberg M
- StudyArch Gynecol Obstet2024 OctReal-life clinical benefit of oral metronomic cyclophosphamide administration in elderly and heavily pretreated epithelial ovarian cancer patients.Attianese D, et al.
- StudyBiomaterials2024 OctImmune modulation of the liver metastatic colorectal cancer microenvironment via the oral CAPOX-mediated cGAS-STING pathway.Park SJ, et al.
- ReviewChilds Nerv Syst2024 OctChemotherapy in pediatric low-grade gliomas (PLGG).Lassaletta A, et al.
- StudyCancer Res Treat2024 OctMetronomic S-1 Adjuvant Chemotherapy Improves Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma.Yu YF, et al.
- Case reportVeterinaryAnimals (Basel)2024 Sep 9Intensive Multimodal Chemotherapy in a Dog Suffering from Grade III/Stage IV Solid Mammary Carcinoma.Beaudu-Lange C and Lange E
- Randomized trialNat Med2024 SepMetronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial.Mo H, et al.
- CommentaryOral Oncol2024 SepLetter to the editor, "Letter to the editor, "Short-term versus long-term metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A propensity score-matched real-world study.".Shanmugam G
- StudyOral Oncol2024 SepShort-term versus long-term metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A propensity score-matched real-world study.Dong S, et al.
- ReviewSmall2024 SepAdvances in Nanomaterials for Immunotherapeutic Improvement of Cancer Chemotherapy.Liu J, et al.
- StudyDig Liver Dis2024 SepSorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care.Stefanini B, et al.
- Case reportVeterinaryFront Vet Sci2024Case report: One-stage craniectomy and cranioplasty digital workflow for three-dimensional printed polyetheretherketone implant for an extensive skull multilobular osteochondosarcoma in a dog.Hobert M, et al.
- ReviewCancer Lett2024 Aug 28"Cyclophosphamide and analogues; a matter of dose and schedule for dual anticancer activities".Delahousse J, et al.
- StudyJ Immunother Precis Oncol2024 AugNovel Effective Therapeutic Regimen for Recurrent/Metastatic Head and Neck Squamous Cell Cancer: Concurrent Triple Oral Metronomic Chemotherapy and Immunotherapy.Limaye S, et al.
- StudyInt J Mol Sci2024 Aug 13Molecular Iodine Improves the Efficacy and Reduces the Side Effects of Metronomic Cyclophosphamide Treatment against Mammary Cancer Progression.Delgado-González E, et al.
- ReviewJ Maxillofac Oral Surg2024 AugOral Metronomic Chemotherapy in Advanced and Metastatic Oral Squamous Cell Carcinoma: A Need of the Hour.Kumar NAN, et al.
- StudyPediatr Blood Cancer2024 AugRetrospective experience of children with relapsed brain tumors treated with oral combination of axitinib and metronomic etoposide.Donzé C, et al.
- CommentaryAsian J Surg2024 AugEfficacy and safety of metronomic cyclophosphamide combined with abiraterone and dexamethasone in heavily pretreated metastatic castration-resistant prostate cancer: A retrospective, real-world study.Zhang L, et al.
- StudyFront Pharmacol2024Promotion of tumor angiogenesis and growth induced by low-dose antineoplastic agents via bone-marrow-derived cells in tumor tissues.You H, et al.
- StudyWorld J Clin Oncol2024 Jul 24Parthenolide enhances the metronomic chemotherapy effect of cyclophosphamide in lung cancer by inhibiting the NF-kB signaling pathway.Cai Z, et al.
- Case reportVeterinaryFront Vet Sci2024Case report: Allogeneic feline umbilical cord-derived mesenchymal stem cell transplantation for feline oral squamous cell carcinoma.Park MK and Song KH
- ReviewAnn Med Surg (Lond)2024 SepSynergistic effects of herpes oncolytic virus and cyclophosphamide for recurrent malignant glioma: a narrative review.Iqbal J, et al.
- ReviewCell Rep Med2024 Jul 16Modulating cancer mechanopathology to restore vascular function and enhance immunotherapy.Mpekris F, et al.
- ReviewCancer Lett2024 Jul 10Nanoparticle-mediated metronomic chemotherapy in cancer: A paradigm of precision and persistence.Kirti A, et al.
- Randomized trialLancet Oncol2024 JulIrinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial.Corbacioglu S, et al.
- StudyJ Pediatr Hematol Oncol2024 Jul 1Metronomic Chemotherapy for Pediatric Refractory Solid Tumors: A Retrospective Single-center Study.Sakurai Y, et al.
- StudyPaediatr Drugs2024 JulDistribution of Bevacizumab into the Cerebrospinal Fluid of Children and Adolescents with Recurrent Brain Tumors.Minichmayr IK, et al.
- StudyJ Oncol Pharm Pract2024 JulA retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy.Gebbia V, et al.
- ReviewCell Rep Med2024 Jun 18Enhancing efficacy and reducing toxicity: Therapeutic optimization in locoregionally advanced nasopharyngeal carcinoma.Jiang W, et al.
- ReviewVeterinaryFront Vet Sci2024Metronomic chemotherapy: bridging theory to clinical application in canine and feline oncology.Petrucci GN, et al.
- ReviewTheranostics2024Metronomic chemotherapy in cancer treatment: new wine in an old bottle.Wu HL, et al.
- StudyIndian J Surg Oncol2024 JunCombined Metronomic Chemo-immunotherapy (CMCI) in Head and Neck Cancers-An Experience from a Developing Country.Madabhavi I, et al.
- ReviewCancer Lett2024 Jun 1Metronomic chemotherapy in hematology: Lessons from preclinical and clinical studies to build a solid rationale for future schedules.Banchi M, et al.
- Randomized trialBreast2024 JunPhase II randomized trial comparing metronomic anthracycline-containing chemotherapy versus standard schedule in untreated HER2 negative advanced breast cancer: activity and quality of life results of the GOIM 21003 trial.Orlando L, et al.
- StudyMath Biosci2024 JunA mathematical model to study low-dose metronomic scheduling for chemotherapy.Arora G, et al.
- ReviewFront Cell Dev Biol2024Optimizing cancer therapy: a review of the multifaceted effects of metronomic chemotherapy.Basar OY, et al.
- StudyEur J Obstet Gynecol Reprod Biol X2024 JunTo study the survival outcomes of uncommon recurrences among patients with cervical cancer compared with loco-regional and nodal recurrences at a tertiary care center in North East India - Bridging the knowledge gap in the existing literature.Kumar M, et al.
- StudyBMC Immunol2024 May 6Effect of immune-modulating metronomic capecitabine as an adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma.He Q, et al.
- ReviewWounds2024 MayMultimodality management of locoregionally extensive Marjolin ulcer: a case report and review of the literature.Mitra S, et al.
- StudyJCO Glob Oncol2024 MayEvaluation of Metronomic Therapy as a Low-Cost, Sustainable, Standard-of-Care Option in Desmoid Fibromatosis: Real-World Data From a Tertiary Care Center in India.Bajpai J, et al.
- CommentaryJCO Glob Oncol2024 MayBuilding the Evidence for Systemic Treatment in Desmoid Fibromatosis: Is a New Metronomic Regimen Another Layer in the Foundation?Alcindor T
- Clinical trialESMO Open2024 MayA new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trial.von Arx C, et al.
- StudyJ Control Release2024 MayContinuous iontronic chemotherapy reduces brain tumor growth in embryonic avian in vivo models.Handl V, et al.
- StudyBr J Cancer2024 MayTumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro.Cao Q, et al.
- ReviewCancer Lett2024 Apr 28Evolution and contemporary role of metronomic chemotherapy in the treatment of neuroblastoma.Chou SW and Chang HH
- Clinical trialBreast Cancer (Dove Med Press)2024Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial.Chen Y, et al.
- StudyIndian J Hematol Blood Transfus2024 AprChallenges in Administering Salvage Therapy and Outcomes of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients: A LMIC Real-World Study.Singh C, et al.
- StudyVeterinaryCan Vet J2024 AprA retrospective study of chemotherapeutic effect without wide-margin surgery or radiation therapy in dogs with oral malignant melanoma.Xia Y, et al.
- ReviewCurr Oncol Rep2024 AprMetronomic Chemotherapy in Elderly Patients.Bandini A, et al.
- Randomized trialBreast2024 AprSingle-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study.Freyer G, et al.
- StudyClin Genitourin Cancer2024 AprTherapy With Metronomic Cyclophosphamide (mCyc) for Previously-Treated Metastatic Castrate-Resistant Prostate Cancer (mCRPC).Mar N, et al.
- StudyAm J Cancer Res2024Higher overall survival rates of oral squamous cell carcinoma treated with metronomic neoadjuvant chemotherapy.Kina S, et al.
- StudyEur J Cancer2024 MarMultiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00.Rusakiewicz S, et al.
- ReviewSemin Cell Dev Biol2024 Mar 1Thrombospondin-1 in drug activity and tumor response to therapies.Longhi E, et al.
- CommentaryFront Oncol2024Editorial: Integrating transcriptional modulation in systemic tumor therapy.Heudobler D, et al.
- StudyVeterinaryJ Am Vet Med Assoc2024 Jul 1Treatment of retroperitoneal sarcoma results in improved outcomes.Walter KM, et al.
- Case reportFront Pharmacol2024Case report: Sustained complete remission with all-oral MEPED therapy in a patient with Hodgkin's disease developing resistance to pembrolizumab.Reuthner K, et al.
- Clinical trialMol Cancer2024 Feb 20Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamide.Toulmonde M, et al.
- StudyMol Cancer2024 Feb 19Impact of metronomic trabectedin combined with low-dose cyclophosphamide on sarcoma microenvironment and correlation with clinical outcome: results from the TARMIC study.Sun CM, et al.
- StudyNPJ Syst Biol Appl2024 Feb 9Mitigating non-genetic resistance to checkpoint inhibition based on multiple states of immune exhaustion.Kareva I and Gevertz JL
- StudyJ Cancer Res Clin Oncol2024 Feb 8Metronomic cyclophosphamide for bone marrow carcinomatosis in metastatic castration-resistant prostate cancer.Peres T, et al.
- Clinical trialEur J Cancer2024 FebMETRO-PD1: Phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors.André N, et al.
- StudyInt J Oncol2024 FebDual‑directional effect of vinorelbine combined with cisplatin or fluorouracil on tumor growth and metastasis in metronomic chemotherapy in breast cancer.Liu H, et al.
- StudyBr J Cancer2024 FebLow-dose metronomic cisplatin as an antiangiogenic and anti-inflammatory strategy for cancer.Kikuchi H, et al.
- Randomized trialBreast Cancer Res Treat2024 FebA randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer.Mayer EL, et al.
- StudyFundam Clin Pharmacol2024 FebDose-dependent bidirectional pharmacological effects of vinorelbine-based metronomic combination chemotherapy on tumor growth and metastasis and mechanisms in melanoma mouse model.Liu H, et al.
- StudyCureus2024 JanEfficacy and Safety of Oral Metronomic Chemotherapy in Recurrent Refractory Advanced Gynaecological Cancer: An Experience From the Regional Cancer Centre of Eastern India.Ghosh R, et al.
- StudyGene2024 Jan 30Whole exome sequencing uncovers HRAS mutations as potential mediators of resistance to metronomic chemotherapy.Sambath J, et al.
- StudyBiomedicines2024 Jan 25Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer.Ilari A, et al.
- ReviewHeliyon2024 Feb 15Metronomic chemotherapy and drug repurposing: A paradigm shift in oncology.Jan N, et al.
- Case reportHeliyon2024 Jan 30An epidermal growth factor receptor-mutated lung adenocarcinoma patient with brain lesions resisted to osimertinib monotherapy but achieved more than 4 years of survival in osimertinib plus bevacizumab metronomic treatment.Liu J, et al.
- ReviewFront Oncol2023Peroxisome proliferator-activated receptorα/γ agonist pioglitazone for rescuing relapsed or refractory neoplasias by unlocking phenotypic plasticity.Harrer DC, et al.
- StudyBMC Res Notes2024 Jan 2Metronomic cyclophosphamide and metformin inhibited tumor growth and repopulated tumor-infiltrating lymphocytes in an experimental carcinoma model.Zaki HM, et al.
- StudyExplor Target Antitumor Ther2024Hexachlorobenzene as a differential modulator of the conventional and metronomic chemotherapy response in triple negative breast cancer cells.Sanchez Y, et al.
- Meta-analysisJ Oncol Pharm Pract2024 JanA review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine.Martorana F, et al.
- StudyMed Oral Patol Oral Cir Bucal2024 Jan 1Proliferative verrucous leukoplakia/multifocal leukoplakia in patients with and without oral submucous fibrosis.Hazarey V, et al.
- Case reportChemotherapy2024Complete Remission of a Diffuse Large B-Cell Lymphoma in a Young Patient, with Severe Tuberous Sclerosis, Treated with Metronomic Chemotherapy and Ibrutinib: A Case Report.Banchi M, et al.